Back to search

University of Ioannina

Μοριακοί μηχανισμοί δράσης των μικρών GTPασών στις αγγειογενετικές αποκρίσεις των ενδοθηλιακών κυττάρων: Ο ρόλος της RHOD στη ρύθμιση του κυτταρικού κύκλου

Abstract

dc:description

The human Rho family of small GTPases represents a major branch of the Ras superfamily, best documented for the regulation of the actin cytoskeleton. In mammalian cells, numerous members of the Rho family have been identified and can be divided into the following groups: Rho (RhoA, B, C), RhoD (RhoD, Rif), Rnd (Rnd1, 2, 3/RhoE), RhoH, RhoBTB (1, 2), Rac (1, 2, 3, RhoG), Cdc42 (Cdc42, TC10/RhoQ, TCL/RhoJ, Wrch1/RhoV, Chp/Wrch2 /RhoU)[Boureux, 2007 #3943]. Small GTPases participate in the regulation of a wide variety of processes such as actin polymerisation, the formation of cellular protrusions, vesicular trafficking, transcriptional regulation, cell motility and cell cycle (reviewed in Etienne-Manneville, 2002 ; Jaffe & Hall, 2005). The most recently evolved member of the Rho family, RhoD, is localized on early endosomes, through which it alters membrane dynamics in the endocytic pathway (Murphy, 1996) and inhibits the motility of endothelial (Murphy, 2001) and 10T1/2 cells (Tsubakimoto, 1999). Moreover, RhoD induces the disassembly of stress fibers and focal adhesions (Murphy, 1996) and may antagonize the effect of RhoA at least on stress fiber formation (Tsubakimoto, 1999). To gain insight into the function of RhoD in vivo, our lab has generated transgenic mice expressing the activated mutant of RhoD, RhoDG26V, in the skin (unpublished results). The mice exhibited epidermal hyperproliferation which clearly implicated RhoD in cell cycle regulation. In the present study, we investigated the role of RhoD during the cell cycle progression, the mechanism involved and the effector through which this regulation occurs. The system we chose to work with was primary endothelial cells as they are well synchronized and can be induced to proliferate with growth factors such as VEGF, furthermore RhoD is also expressed in this cell type. Combined experiments of methyl [³H]-thymidine or 5-bromo-2-deoxyuridine incorporation and FACS analysis, verified that RhoD affects G1/S transition. Even though myc-RhoDG26V did not enhance cell proliferation, over-expression of the wild-type protein was sufficient to increase the number of cells in S phase, whereas a dominant negative RhoD mutant and RhoD siRNAs inhibited G1/S transition. To ensure that RhoD or mutants do not affect proliferation by inhibiting VEGF induced activation of ERK1/2, the main mitotic cascade of VEGF (Marchall, 1995), we tested the ERK1/2 MAPK phosphorylation upon VEGF administration. In all cases, there was no effect on VEGF-induced phosphorylation of ERK1/2, indicating that RhoD does not affect endothelial cell proliferation by altering the mitogenic signal of VEGF (upstream of ERK1/2), but probably through a direct effect in the regulation of cell cycle progression. During the control of the specificity of the siRNAs against RhoD, we saw indeed that there was no downregulation of the mRNA levels of the related Rho proteins, but interestingly there was an increase in RhoB mRNA. RhoB is a known regulator of cell proliferation (Liu and Prendergast, 2000; Mazieres et al., 2004) and to address whether the effect of RhoD knockdown on cell proliferation was due to its increase in RhoB, we carried out a double knockdown of both RhoD and RhoB and estimated BrdU incorporation. As the double knockdown caused also inhibition of BrdU incorporation, we conclude that the effect of RhoD on cell proliferation is independent of its effect on RhoB. Furthermore, the role of RhoD in cell cycle progression was not mediated through its only known effector, hDia2C. During the course of our experiments, we observed that myc-RhoDG26V caused significant nuclear fragmentation and multi-nucleation. Nuclear fragmentation results from abnormalities during karyokinesis, whereas multi-nucleation stems from inhibition of cytokinesis. Analysis of the activation state of RhoD during the various stages of M phase, indicated an increase of RhoD activation during early steps of mitosis and a decrease towards the exit of M. The punctate (endosomal) localization of RhoDWT/G26V did not change during mitosis, and again hDia2C did not mediate the effects of RhoD in M phase. Therefore with regard to cyctokinesis defects we suspect that a continued activation of RhoD at a phase of mitosis where the protein is not normally active causes mislocalization of myosin 2 and cytokinesis defects. With respect to nuclear fragmentation the mechanism of action of RhoD is unclear however we observed that RhoD localizes to the peri-centrosomal area and perhaps may play a role in centrosome duplication and/or maturation – this requires further investigation. As the known effector of RhoD did not mediate the cell cycle effects described above, we set out to identify RhoD-interacting proteins playing a role in S and/or M phase regulation, and used the yeast two-hybrid system. We identified Diaphanous 1 as a novel RhoD effector and validated the interaction using a series of independent biochemical and microscopic approaches. Our results indicate that this molecule is indeed the mediator of RhoD during the regulation of the cell cycle progression, which is consistent with established data regarding the role of Diaphanous 1 in the above process. In conclusion, our study indicates that the cycling of RhoD, between the inactive GDP and active GTP forms, requires a strict regulation for proper progression of the cell cycle. The effect of RhoD in the progression of the cell cycle seems to be mediated by a novel effector, Diaphanous 1.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kyrkou, Athena
  • Κύρκου, Αθηνά

Subjects

dc:subject × 11

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27146

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kyrkou, Athena; Κύρκου, Αθηνά. Μοριακοί μηχανισμοί δράσης των μικρών GTPασών στις αγγειογενετικές αποκρίσεις των ενδοθηλιακών κυττάρων: Ο ρόλος της RHOD στη ρύθμιση του κυτταρικού κύκλου. University of Ioannina, 2009. http://hdl.handle.net/10442/hedi/27146